Viewing Study NCT03801304


Ignite Creation Date: 2025-12-24 @ 7:54 PM
Ignite Modification Date: 2026-01-05 @ 5:32 PM
Study NCT ID: NCT03801304
Status: COMPLETED
Last Update Posted: 2022-05-12
First Post: 2019-01-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
Sponsor: University Hospital, Brest
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-01-24
Start Date Type: ACTUAL
Primary Completion Date: 2021-01-04
Primary Completion Date Type: ACTUAL
Completion Date: 2022-02-23
Completion Date Type: ACTUAL
First Submit Date: 2019-01-07
First Submit QC Date: None
Study First Post Date: 2019-01-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-05-11
Last Update Post Date: 2022-05-12
Last Update Post Date Type: ACTUAL